HAVCR1 anticorps (AA 230-280)
Aperçu rapide pour HAVCR1 anticorps (AA 230-280) (ABIN6990296)
Antigène
Voir toutes HAVCR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 230-280
-
Purification
- TIM-1 Antibody is affinity chromatography purified via peptide column.
-
Immunogène
- Anti-TIM-1 antibody was raised against a peptide corresponding to 16 amino acids near the center terminus of human TIM-1. The immunogen is located within amino acids 230 - 280 of TIM-1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1-8 μ,g/mL
Antibody validated: Western Blot in human samples. All other applications and species not yet tested -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- TIM-1 Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,4 °C
-
Stockage commentaire
- TIM-1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- HAVCR1 (Hepatitis A Virus Cellular Receptor 1 (HAVCR1))
-
Autre désignation
- TIM-1
-
Classe de substances
- Virus
-
Sujet
- TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma.
-
Poids moléculaire
-
Predicted: 44kD
Observed: 60kD (Post-modification: 4 N-linked glycosylation) kDa -
ID gène
- 26762
-
NCBI Accession
- NP_036338
-
UniProt
- Q96D42
Antigène
-